1
Mean corrected QT dispersion was significantly higher in cases compared with controls.
2
The diagnosis is problematic in individuals with borderline or even normal corrected QT interval value.
3
Corrected QT interval measurements were obtained from participants and subsequent genotyping of relatives was carried out.
4
Background: Antipsychotics have been associated with prolongation of the corrected QT interval and sudden cardiac death.
5
Corrected QT interval was not affected.
6
Chloroquine caused decrease in heart rate and increase in the corrected QT (QTc) interval in both the models.
7
In other 3 members borderline corrected QT interval values were found (0.44-0.46 s).
8
The results obtained with the modified Holter bin method are practically the same as with individualized heart rate corrected QT intervals.
9
Results: We found strong associations between both daytime and night-time blood pressure and heart-rate- corrected QT interval dispersion (QTc dispersion).
10
K(+) current reduction in high estrogenic conditions were associated with prolongation of the action potential duration and corrected QT interval.
11
A sex specific coefficient was calculated in each group and was used to calculate group specific corrected QT intervals (QTci).
12
Aims: Identification of a prolonged, corrected QT (QTc) interval in athletes may be a recommendation for disqualification from competitive sports.
13
Drug-induced prolongation of the heart rate corrected QT interval (QTcF) was compared with changes in the computerized measure for T-wave morphology.
14
Heart rate variability parameters indicating sympathetic and parasympathetic modulation showed strong correlations with heart-rate- corrected QT interval (QTc interval) and with QTc dispersion.
15
Telemetric electrocardiographic recordings of awake mice revealed prolongation of the corrected QT interval in the KO compared with WT control mice, with overt ventricular arrhythmias.
16
Aim: To evaluate the interaction between sex and rate corrected QT interval (QTc) duration in normal subjects after drug-induced QT prolongation and in LQTS patients.